The research, which was conducted on mice, demonstrates how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface. Led by the IBEC and CIC biomaGUNE, the study opens the door to new, more efficient treatments for bladder cancer.
Teresa Sanchis and Xavier Trepat, members of IBEC, have authored opinion pieces in the ‘World View’ section of Nature Physics. Both articles underscore IBEC’s dedication to scientific excellence, the promotion of diversity, and the cultivation of an environment conducive to collaboration. They also highlight the relevant role of IBEC at the international level in multidisciplinary research.
Inside Nature Nanotechnology, an editor’s view Christine Horejs, Nature Nanotechnology Nature Nanotechnology was launched in October 2006 with the aim of publishing the most significant results in fundamental aspects, applications … Read more
Inside Nature Nanotechnology, an editor’s view Christine Horejs, Nature Nanotechnology Nature Nanotechnology was launched in October 2006 with the aim of publishing the most significant results in fundamental aspects, applications … Read more
Researchers at the Autonomous University of Barcelona (UAB) and Institute for Bioengineering of Catalonia (IBEC) have revealed a way to effectively deliver a mycobacterium needed for the treatment of bladder cancer in humans –using a formulation based on olive oil.The researchers have found a way to reduce the natural clumping that occurs when mycobacteria cells, which possess a high content of lipids in their walls, are introduced to the usual aqueous solutions that are used for intravesical instillation in bladder cancer patients. This clumping may interfere with the interaction of the mycobacteria-host cells and negatively influence their antitumor effects.